Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › AR › HEBER SPRINGS › BAPTIST HEALTH

BAPTIST HEALTH

NPI: 1609804822 · HEBER SPRINGS, AR 72543 · Rehabilitation Clinic/Center · NPI assigned 06/28/2006

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WELLS, TROY controls 20+ related entities in our dataset. Read more

$3.69M
Total Medicaid Paid
179,558
Total Claims
144,388
Beneficiaries
158
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialWELLS, TROY (PRESIDENT)
NPI Enumeration Date06/28/2006

Related Entities

Other providers sharing the same authorized official: WELLS, TROY

ProviderCityStateTotal Paid
BAPTIST HEALTH REGIONAL HOSPITALS FORT SMITH AR $17.49M
BAPTIST HEALTH LITTLE ROCK AR $16.48M
BAPTIST HEALTH NORTH LITTLE ROCK AR $14.02M
BAPTIST HEALTH ARKADELPHIA AR $4.82M
CONWAY COMMUNITY SERVICES CONWAY AR $4.12M
BAPTIST HEALTH HOSPITALS STUTTGART AR $2.97M
BAPTIST HEALTH LITTLE ROCK AR $2.93M
BAPTIST HEALTH MALVERN AR $2.68M
BAPTIST HEALTH REGIONAL HOSPITALS VAN BUREN AR $2.46M
BAPTIST HEALTH LITTLE ROCK AR $1.83M
BAPTIST HEALTH ARKADELPHIA AR $1.51M
BAPTIST HEALTH HOSPITALS STUTTGART AR $901K
BAPTIST HEALTH LITTLE ROCK AR $780K
BAPTIST HEALTH NORTH LITTLE ROCK AR $411K
BAPTIST HEALTH MONTICELLO AR $367K
BAPTIST HEALTH CONWAY AR $142K
BAPTIST HEALTH LITTLE ROCK AR $88K
BAPTIST HEALTH PRESCOTT AR $33K
BAPTIST HEALTH MALVERN AR $31K
BAPTIST HEALTH HEBER SPRINGS AR $22K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 21,272 $366K
2019 28,962 $510K
2020 24,797 $469K
2021 29,157 $618K
2022 34,095 $692K
2023 23,563 $583K
2024 17,712 $452K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
80053 Comprehensive metabolic panel 11,855 9,835 $548K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 2,940 2,709 $388K
70450 Computed tomography, head or brain; without contrast material 2,275 1,944 $316K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 7,237 1,786 $245K
80048 Basic metabolic panel (calcium, ionized) 5,028 4,220 $237K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2,351 2,130 $220K
74177 Computed tomography, abdomen and pelvis; with contrast material 1,316 1,155 $197K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 15,320 12,357 $100K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1,642 1,343 $74K
80050 General health panel 1,593 1,518 $74K
80076 2,016 1,773 $71K
74176 Computed tomography, abdomen and pelvis; without contrast material 788 705 $71K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2,877 2,355 $51K
36415 Collection of venous blood by venipuncture 7,781 6,477 $45K
71046 Radiologic examination, chest; 2 views 2,436 2,076 $41K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 4,136 3,443 $40K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2,955 2,487 $36K
84484 3,507 2,664 $36K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,750 1,531 $35K
80061 Lipid panel 3,140 2,933 $34K
96361 Intravenous infusion, hydration; each additional hour 1,364 1,053 $34K
84443 Thyroid stimulating hormone (TSH) 3,383 3,110 $31K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 570 476 $31K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 369 330 $31K
83880 1,674 1,412 $30K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2,372 2,226 $30K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 586 566 $28K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 75 66 $27K
71045 Radiologic examination, chest; single view 3,727 3,178 $27K
83605 2,528 1,933 $27K
96375 Therapeutic injection; each additional sequential IV push 2,059 1,630 $25K
82550 2,929 2,404 $23K
80305 1,726 1,512 $22K
72100 524 459 $19K
87088 2,472 2,172 $19K
87040 2,427 1,365 $19K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 5,062 4,548 $19K
83690 2,372 2,086 $18K
J2405 Injection, ondansetron hydrochloride, per 1 mg 3,534 2,812 $18K
81025 1,851 1,644 $18K
87631 261 233 $18K
81001 4,873 4,155 $16K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 387 354 $15K
72125 Computed tomography, cervical spine; without contrast material 135 119 $13K
83036 Hemoglobin; glycosylated (A1C) 1,538 1,479 $12K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 107 81 $12K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 319 221 $12K
85027 1,907 1,602 $11K
82150 1,354 1,221 $10K
99283 Emergency department visit for the evaluation and management, moderate severity 903 724 $10K
82077 555 463 $10K
83735 1,567 1,313 $9K
99284 Emergency department visit for the evaluation and management, high severity 1,413 1,171 $9K
81003 4,245 3,802 $8K
J1885 Injection, ketorolac tromethamine, per 15 mg 2,885 2,301 $7K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,223 1,061 $7K
87077 845 759 $7K
97032 306 63 $6K
77067 Screening mammography, bilateral, including computer-aided detection 125 112 $6K
96376 231 167 $6K
87086 Culture, bacterial; quantitative colony count, urine 876 796 $6K
80179 295 244 $6K
73630 185 169 $6K
85610 2,128 1,738 $5K
80143 280 239 $5K
J0696 Injection, ceftriaxone sodium, per 250 mg 1,399 1,177 $5K
82962 595 315 $5K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,058 844 $5K
82803 277 214 $4K
80306 221 167 $4K
97161 80 72 $4K
88305 Level IV - Surgical pathology, gross and microscopic examination 12 12 $4K
73560 137 107 $4K
87186 798 716 $3K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 147 134 $3K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 18 14 $3K
85379 345 311 $3K
73610 114 107 $3K
97001 112 88 $3K
87420 172 169 $2K
82607 185 170 $2K
71020 206 180 $2K
82375 277 218 $2K
72040 67 56 $2K
74018 123 110 $2K
71275 Computed tomographic angiography, chest, with contrast material 12 12 $2K
86803 135 127 $2K
80320 106 75 $2K
72131 14 14 $2K
86900 31 23 $1K
J2704 Injection, propofol, 10 mg 1,312 1,105 $1K
80069 168 151 $1K
82805 65 48 $1K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 101 82 $1K
73110 27 26 $1K
73030 63 57 $1K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 21 18 $997.65
85730 267 242 $928.85
73562 12 12 $861.21
80329 44 31 $792.66
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 603 539 $774.79
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 52 40 $750.50
82248 152 137 $747.20
82947 158 105 $660.51
76830 Ultrasound, transvaginal 13 12 $635.80
85007 233 190 $609.29
74019 35 29 $599.85
71010 102 95 $585.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 973 783 $573.05
84450 127 107 $558.78
84460 122 103 $542.19
74022 26 24 $518.27
J7030 Infusion, normal saline solution , 1000 cc 2,060 1,698 $511.19
36600 292 243 $488.56
73502 15 12 $460.70
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 174 128 $450.29
J2270 Injection, morphine sulfate, up to 10 mg 1,456 1,169 $428.27
84703 27 27 $358.20
86901 31 23 $357.00
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 21 20 $342.27
85055 26 25 $333.02
77063 Screening digital breast tomosynthesis, bilateral 13 13 $280.12
94760 25 24 $280.00
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 31 29 $278.11
J7050 Infusion, normal saline solution, 250 cc 2,888 1,699 $238.17
82247 46 32 $216.50
82728 28 24 $211.68
J1170 Injection, hydromorphone, up to 4 mg 459 359 $198.01
87807 14 13 $187.34
J2060 Injection, lorazepam, 2 mg 75 56 $183.68
73130 16 13 $183.54
87400 14 13 $149.44
84075 32 26 $141.86
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1,653 1,512 $126.00
86140 13 12 $118.53
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 13 13 $115.22
J0690 Injection, cefazolin sodium, 500 mg 200 157 $109.05
J3010 Injection, fentanyl citrate, 0.1 mg 340 294 $100.22
86780 17 17 $93.20
87070 23 22 $77.12
87340 14 14 $70.32
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 80 74 $64.04
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 21 17 $60.00
J2250 Injection, midazolam hydrochloride, per 1 mg 163 133 $50.65
86762 14 14 $48.99
87205 18 17 $32.15
A9270 Non-covered item or service 2,585 701 $25.45
82746 17 13 $21.00
81015 36 34 $20.77
J7120 Ringers lactate infusion, up to 1000 cc 1,179 864 $13.77
85652 20 13 $11.55
J2550 Injection, promethazine hcl, up to 50 mg 72 52 $6.21
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 422 302 $1.17
J1200 Injection, diphenhydramine hcl, up to 50 mg 16 13 $0.60
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 18 13 $0.08
0353U 34 30 $0.00
86850 27 21 $0.00
G0103 Prostate cancer screening; prostate specific antigen test (psa) 13 12 $0.00